Skip to main content
. 2016 Oct 10;7(5):352–369. doi: 10.5306/wjco.v7.i5.352

Figure 2.

Figure 2

A schematic figure showing the complementary effects of phosphatidylinositol 3-kinase/Akt inhibitors with platinum agents, taxanes, antimetabolites, tumor antibiotics, and radiation resulting in a better cytotoxic profile.